Are There Any Detrimental Effects of the Use of Inhaled Long-Acting β2-Agonists in the Treatment of Asthma?

This publication has 45 references indexed in Scilit:

• Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.
  Thorax, 1993
• Bronchodilator treatment in asthma.
  BMJ, 1993
• Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
  BMJ, 1993
• Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.
  BMJ, 1993
• Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
  Thorax, 1993
• Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler.
  BMJ, 1992
• Twelve months, treatment with inhaled salmeterol in asthmatic patients
  Allergy, 1992
• The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours
  Journal of Allergy and Clinical Immunology, 1992
• Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.
  BMJ, 1991
• Protection against allergen-induced asthma by salmeterol
  The Lancet, 1990